이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Pediatrix Medical Group 과거 수익 실적
과거 기준 확인 0/6
Pediatrix Medical Group의 수입은 연평균 -20.6%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 5.6%의 비율로 증가했습니다. 매출은 연평균 3.2%의 비율로 감소해 왔습니다.
주요 정보
-20.6%
수익 성장률
-19.3%
EPS 성장률
| Healthcare 산업 성장 | 8.5% |
| 매출 성장률 | -3.2% |
| 자기자본 수익률 | -8.2% |
| 순이익 | -3.5% |
| 최근 수익 업데이트 | 31 Mar 2024 |
최근 과거 실적 업데이트
Recent updates
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19
Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08Is MEDNAX (NYSE:MD) A Risky Investment?
Jul 19MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital
Jun 27Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are
May 15Mednax Q1 2021 Earnings Preview
May 06수익 및 비용 분석
수익 및 비용 분석
Pediatrix Medical Group 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 31 Mar 24 | 1,999 | -71 | 229 | 0 |
| 31 Dec 23 | 1,995 | -60 | 228 | 0 |
| 30 Sep 23 | 2,012 | 88 | 226 | 0 |
| 30 Jun 23 | 1,995 | 95 | 226 | 0 |
| 31 Mar 23 | 1,981 | 98 | 229 | 0 |
| 31 Dec 22 | 1,972 | 63 | 231 | 0 |
| 30 Sep 22 | 1,957 | 79 | 239 | 0 |
| 30 Jun 22 | 1,960 | 82 | 248 | 0 |
| 31 Mar 22 | 1,947 | 82 | 258 | 0 |
| 31 Dec 21 | 1,911 | 108 | 263 | 0 |
| 30 Sep 21 | 1,829 | 72 | 259 | 0 |
| 30 Jun 21 | 1,797 | 38 | 259 | 0 |
| 31 Mar 21 | 1,739 | 14 | 248 | 0 |
| 31 Dec 20 | 1,734 | -10 | 249 | 0 |
| 30 Sep 20 | 1,776 | -4 | 253 | 0 |
| 30 Jun 20 | 1,770 | 11 | 250 | 0 |
| 31 Mar 20 | 1,678 | 1 | 230 | 0 |
| 31 Dec 19 | 1,780 | 42 | 245 | 0 |
| 30 Sep 19 | 2,210 | 94 | 291 | 0 |
| 30 Jun 19 | 2,603 | 143 | 323 | 0 |
| 31 Mar 19 | 3,145 | 221 | 384 | 0 |
| 31 Dec 18 | 1,723 | 122 | 232 | 0 |
| 30 Sep 18 | 3,477 | 333 | 450 | 0 |
| 30 Jun 18 | 3,497 | 337 | 456 | 0 |
| 31 Mar 18 | 3,475 | 326 | 458 | 0 |
| 31 Dec 17 | 3,253 | 305 | 386 | 0 |
| 30 Sep 17 | 3,378 | 262 | 443 | 0 |
| 30 Jun 17 | 3,337 | 293 | 435 | 0 |
| 31 Mar 17 | 3,266 | 312 | 424 | 0 |
| 31 Dec 16 | 3,183 | 325 | 411 | 0 |
| 30 Sep 16 | 3,094 | 340 | 393 | 0 |
| 30 Jun 16 | 2,988 | 334 | 379 | 0 |
| 31 Mar 16 | 2,893 | 336 | 360 | 0 |
| 31 Dec 15 | 2,780 | 336 | 338 | 0 |
| 30 Sep 15 | 2,689 | 332 | 316 | 0 |
| 30 Jun 15 | 2,593 | 327 | 296 | 0 |
| 31 Mar 15 | 2,512 | 322 | 285 | 0 |
| 31 Dec 14 | 2,439 | 317 | 275 | 0 |
| 30 Sep 14 | 2,356 | 308 | 262 | 0 |
| 30 Jun 14 | 2,284 | 299 | 256 | 0 |
| 31 Mar 14 | 2,218 | 289 | 250 | 0 |
| 31 Dec 13 | 2,154 | 281 | 245 | 0 |
| 30 Sep 13 | 2,058 | 268 | 237 | 0 |
양질의 수익: MD 은(는) 현재 수익성이 없습니다.
이익 마진 증가: MD 은(는) 현재 수익성이 없습니다.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: MD 은(는) 수익성이 없으며 지난 5년 동안 연간 20.6% 비율로 손실이 증가했습니다.
성장 가속화: 현재 수익성이 없기 때문에 MD 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.
수익 대 산업: MD 은(는) 수익성이 없어 지난 해 수익 성장을 Healthcare 업계( 15.1% )와 비교하기 어렵습니다.
자기자본 수익률
높은 ROE: MD 현재 수익성이 없기 때문에 마이너스 자본 수익률( -8.24% )을 갖습니다.